Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q2 2025 · 10-Q
Revenue$7.48K$7.48K−5.0% vs Q2 2024 Net Income-$1.68M-$1.68MN/M vs Q2 2024 EPS Diluted-$0.97-$0.97N/M vs Q2 2024 Operating Income-$1,678,699N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,590,161N/M Margins · derivedOperating margin-22457.5%−6162.0 pt vs Q2 2024
Net margin-22517.7%−6151.8 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end